← Eichor
Study identifier: NCT05408065 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Comparison of the Analgesic Effect of 2 Shoulder Infiltrations

Condition: Infiltration · Shoulder Osteoarthritis  ·  Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

PhaseNA
Planned participants84
Who can joinAll sexes, 20 Years to no upper limit
Healthy volunteersNo

About this study

For patients suffering of osteoarthritis, only analgesic treatments such as anti-inflammatory drugs and cortisone infiltrations provide significant but temporary relief of their pain. The objective is to compare the analgesic effect of 2 infiltrations: Cingal (sodium hyaluronate and triamcinolone) versus cortisone (triamcinolone). It is anticipated that the Cingal infiltration will have a greater analgesic effect than a simple cortisone infiltration in patients with moderate to severe osteoarthritis of the shoulder. Method: * Randomized controlled trial * Monocentric * Randomization will be done using sealed envelopes

This description comes directly from the study's public registry record.

Talk to the study team

Fidaa Al-Shakfa, M.Sc, MBA  ·  5148908000  ·  f.alshakfa.crchum@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Centre Hospitalier de l'Université de Montréal (CHUM)Montreal, Quebec, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05408065